Pulmonx Corp (FRA:4NI)
€ 6.7 0.15 (2.29%) Market Cap: 278.26 Mil Enterprise Value: 229.75 Mil PE Ratio: 0 PB Ratio: 3.17 GF Score: 58/100

Pulmonx Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2022 / 12:30PM GMT
Release Date Price: €26.2 (+1.55%)
Unidentified Analyst

Good morning, everyone, and welcome back to JPMorgan's 40th Annual Healthcare Conference. Very excited to have you all here this morning. I am thrilled to introduce Pulmonx to you this morning. Here we have Glen French, President and CEO, who's very excited to tell you a little bit more about their story. So I'll hand it off to you. Glen, thank you again for being here.

Glendon E. French
Pulmonx Corporation - CEO, President & Director

Lisa, thank you very much. And particularly given that you're in San Francisco, and it's 4:30 in the morning, thank you very much for being here, and I look forward to talking to everybody.

So the -- I'm here today to talk about Pulmonx. I'm the CEO of Pulmonx. I've been with the company for about 7 years and have been in this interventional pulmonology space for the better part of the last 25 years.

I'd like to -- as I move through this presentation, I will reference the slide numbers. My understanding is that everybody has the slides in front of them and can toggle through as we go.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot